Search Results 1261-1270 of 11396 for anti-TNF drugs

  1. Clinical trials - Oncology (Medical)

    This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Filgrastim-aafi (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Filgrastim-aafi injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  4. Tenosynovial giant cell tumor - Diagnosis and treatment - Mayo Clinic

    Discuss the expected benefits and other treatment options with your care team. Targeted therapy. Targeted medicines block certain signals that help TGCT cells ...

  5. Neurology - Clinical trials

    Peripheral Nerve Stimulation Therapy for Atrial Fibrillation. Rochester, Minn. The purpose of this study is to determine and compare the safety and efficacy of ...

  6. Midostaurin And Decitabine In Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia And FLT3 Mutation - Mayo Clinic

    ... treatment cannot be either discontinued or switched to a different medication prior to starting study drug. Prohibited medications contain drugs that should ...

  7. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, work in different ways to stop the growth of tumor cells, either ...

  8. Study Of Pomalidomide For Treatment Of Relapsed/Refractory Primary Central Nervous System Lymphoma And Newly Diagnosed Or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

    Blood brain barrier is an obstacle in treatment of brain tumors such as CNS lymphoma. Pomalidomide was shown to have an excellent CNS penetration in a murine ...

  9. Study identifies potential immunotherapy strategy for early-stage prostate cancer - Mayo Clinic News Network

    ... anti-CTLA-4 therapy can deplete regulatory T cells within prostate tumors. Because the treatment was given before surgery, researchers also were able to ...

  10. ACTIV-5 / Big Effect Trial (BET-B) For The Treatment Of COVID-19 - Mayo Clinic

    Received monoclonal antibodies targeting cytokines (e.g., tumor necrosis factor (TNF) inhibitors, anti-IL-1 [e.g., anakinra, canakinumab], anti-IL-6 [e.g. ...